0001193125-25-283548.txt : 20251114 0001193125-25-283548.hdr.sgml : 20251114 20251114194807 ACCESSION NUMBER: 0001193125-25-283548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251112 FILED AS OF DATE: 20251114 DATE AS OF CHANGE: 20251114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN JEREMY B. CENTRAL INDEX KEY: 0001650737 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 251488946 MAIL ADDRESS: STREET 1: 2 MUSICK STREET 2: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 ownership.xml 4 X0508 4 2025-11-12 0001531177 Sight Sciences, Inc. SGHT 0001650737 HAYDEN JEREMY B. C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE., SUITE 100 MENLO PARK CA 94025 false true false false Chief Legal Officer true Common Stock 2025-11-12 4 M false 2440 1.96 A 259030 D Common Stock 2025-11-12 4 M false 710 1.96 A 259740 D Common Stock 2025-11-12 4 S false 3150 8.01 D 256590 D Stock Option (Right to Buy) 1.96 2025-11-12 4 M false 2440 0 D 2030-05-10 Common Stock 2440 0 D Stock Option (Right to Buy) 1.96 2025-11-12 4 M false 710 0 D 2030-07-28 Common Stock 710 0 D The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions. Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The options are fully vested and exercisable. Jeremy Hayden 2025-11-14